- Home
- MAN vs ATAI Comparison
MAN vs ATAI Comparison
Compare MAN & ATAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MAN | ATAI |
|---|---|---|
| Founded | 1948 | 2018 |
| Country | United States | Netherlands |
| Employees | N/A | N/A |
| Industry | Professional Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.4B |
| IPO Year | 1988 | 2021 |
Fundamental Metrics
Financial Performance| Metric | MAN | ATAI |
|---|---|---|
| Price | $27.93 | $4.33 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 6 | 5 |
| Target Price | ★ $40.67 | $14.00 |
| AVG Volume (30 Days) | 1.0M | ★ 4.1M |
| Earning Date | 10-16-2025 | 11-12-2025 |
| Dividend Yield | ★ 8.04% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $17,643,700,000.00 | $3,018,000.00 |
| Revenue This Year | $1.15 | $943.83 |
| Revenue Next Year | $3.60 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 811.78 |
| 52 Week Low | $26.14 | $1.15 |
| 52 Week High | $63.35 | $6.75 |
Technical Indicators
Market Signals| Indicator | MAN | ATAI |
|---|---|---|
| Relative Strength Index (RSI) | 38.09 | 50.17 |
| Support Level | $27.72 | $3.71 |
| Resistance Level | $29.26 | $4.54 |
| Average True Range (ATR) | 0.99 | 0.23 |
| MACD | 0.32 | 0.10 |
| Stochastic Oscillator | 55.77 | 77.80 |
Price Performance
Historical ComparisonAbout MAN ManpowerGroup
ManpowerGroup Inc. is engaged in providing workforce solutions and services. The company provides services that include Recruitment and Assessment, Upskilling, Reskilling, Training and Development, Career Management, Outsourcing, and Workforce Consulting. The reportable segments of the company are Staffing and Interim, Outcome-Based Solutions and Consulting, Permanent Recruitment, and Others. The Staffing and Interim segment derives the maximum of the company's revenue. The company derives maximum geographical revenue from the Southern European region.
About ATAI ATAI Life Sciences N.V.
Atai Beckley NV is a clinical-stage biopharmaceutical company. It aims to develop mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 and BPL-003 for the treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder.